Literature DB >> 31653509

Evaluation of clear cell subtypes of ovarian and uterine malignancies with anti-PD-L1 and anti-PD1 immunohistochemical expression and their association with stage and survival.

Jill Alldredge1, Tasha Serna-Gallegos2, Nicolas Gallegos2, Jessica Peak VanLeer2, Jenny Chang3, Argyrios Ziogas3, Wamda Goreal2, Leslie Randall2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31653509     DOI： 10.1016/j.ygyno.2019.10.008

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  3 in total

1.  Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.

Authors:  Liju Zong; Qianqian Zhang; Yuncan Zhou; Yujia Kong; Shuangni Yu; Jie Chen; Youzhong Zhang; Yang Xiang
Journal:  J Immunol Res       Date:  2020-04-03       Impact factor: 4.818

2.  Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.

Authors:  Chen Zhang; Qing Yang
Journal:  Front Oncol       Date:  2021-02-01       Impact factor: 6.244

3.  Transcriptome Analysis of Ovarian and Uterine Clear Cell Malignancies.

Authors:  Jill Alldredge; Leslie Randall; Gabriela De Robles; Anshu Agrawal; Dan Mercola; Marisa Liu; Pavneet Randhawa; Robert Edwards; Michael McClelland; Farah Rahmatpanah
Journal:  Front Oncol       Date:  2020-12-22       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.